Home Business Jazz Pharma inks $145M deal to resolve Xyrem antitrust claims Business Jazz Pharma inks $145M deal to resolve Xyrem antitrust claims By hachi - April 9, 2025 8 FacebookTwitterPinterestWhatsApp ad1 Jazz Pharma inks $145M deal to resolve Xyrem antitrust claims ad3
